Literature DB >> 12436964

A versatile and scalable two-step ion-exchange chromatography process for the purification of recombinant adeno-associated virus serotypes-2 and -5.

Nicole Brument1, Robert Morenweiser, Véronique Blouin, Estelle Toublanc, Isabelle Raimbaud, Yan Chérel, Sébastien Folliot, Florence Gaden, Pierre Boulanger, Gabrielle Kroner-Lux, Philippe Moullier, Fabienne Rolling, Anna Salvetti.   

Abstract

Here we describe the development of a two-step chromatography process based on the use of ion-exchange resins for the purification of recombinant adeno-associated virus (rAAV) serotypes-2 and-5. In vitro and in vivo results demonstrate that this method, which does not require any prepurification step of the cell lysate, can be applied to obtain highly pure rAAV2 and rAAV5 stocks. As such,this procedure can be easily transferred in vector cores and also scaled up, allowing the direct comparison of these two, and potentially other, AAV serotypes in large animal models.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12436964     DOI: 10.1006/mthe.2002.0719

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  21 in total

1.  A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells.

Authors:  Richard H Smith; Justin R Levy; Robert M Kotin
Journal:  Mol Ther       Date:  2009-06-16       Impact factor: 11.454

Review 2.  Large-scale recombinant adeno-associated virus production.

Authors:  Robert M Kotin
Journal:  Hum Mol Genet       Date:  2011-04-29       Impact factor: 6.150

3.  Good manufacturing practice production of self-complementary serotype 8 adeno-associated viral vector for a hemophilia B clinical trial.

Authors:  James A Allay; Susan Sleep; Scott Long; David M Tillman; Rob Clark; Gael Carney; Paolo Fagone; Jenny H McIntosh; Arthur W Nienhuis; Andrew M Davidoff; Amit C Nathwani; John T Gray
Journal:  Hum Gene Ther       Date:  2011-05       Impact factor: 5.695

4.  Analysis of particle content of recombinant adeno-associated virus serotype 8 vectors by ion-exchange chromatography.

Authors:  Martin Lock; Mauricio R Alvira; James M Wilson
Journal:  Hum Gene Ther Methods       Date:  2012-02       Impact factor: 2.396

5.  Establishment of a novel cell line for the enhanced production of recombinant adeno-associated virus vectors for gene therapy.

Authors:  Stifani Satkunanathan; Jun Wheeler; Robin Thorpe; Yuan Zhao
Journal:  Hum Gene Ther       Date:  2014-09-11       Impact factor: 5.695

6.  Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale.

Authors:  Martin Lock; Mauricio Alvira; Luk H Vandenberghe; Arabinda Samanta; Jaan Toelen; Zeger Debyser; James M Wilson
Journal:  Hum Gene Ther       Date:  2010-10       Impact factor: 5.695

7.  Process improvement of adeno-associated virus (AAV) production.

Authors:  Jia-Shiung Guan; Kai Chen; Yingnan Si; Taehyun Kim; Zhuoxin Zhou; Seulhee Kim; Lufang Zhou; Xiaoguang Margaret Liu
Journal:  Front Chem Eng       Date:  2022-01-28

Review 8.  Strategies for manufacturing recombinant adeno-associated virus vectors for gene therapy applications exploiting baculovirus technology.

Authors:  Alejandro Negrete; Robert M Kotin
Journal:  Brief Funct Genomic Proteomic       Date:  2008-07-16

9.  AAV2/8 vectors purified from culture medium with a simple and rapid protocol transduce murine liver, muscle, and retina efficiently.

Authors:  Monica Doria; Antonella Ferrara; Alberto Auricchio
Journal:  Hum Gene Ther Methods       Date:  2013-10-11       Impact factor: 2.396

10.  Recombinant adeno-associated virus type 2-mediated gene delivery into the Rpe65-/- knockout mouse eye results in limited rescue.

Authors:  Chooi-May Lai; Meaghan Jt Yu; Meliha Brankov; Nigel L Barnett; Xiaohuai Zhou; T Michael Redmond; Kristina Narfstrom; P Elizabeth Rakoczy
Journal:  Genet Vaccines Ther       Date:  2004-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.